✦ LIBER ✦

Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial

✍ Scribed by Ferrari, Mauro P.; Mantelli, Flavio; Sacchetti, Marta; Antonangeli, Maria Irene; Cattani, Franca; D’Anniballe, Gaetano; Sinigaglia, Francesco; Ruffini, Pier Adelchi; Lambiase, Alessandro

Book ID: 121590483
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 308 KB
Volume: 28
Category: Article
ISSN: 1173-8804
DOI: 10.1007/s40259-013-0079-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and pharmacokinetics of a glycoPE

Safety and pharmacokinetics of a glycoPEGylated recombinant activated factor VII derivative: a randomized first human dose trial in healthy subjects

✍ J. MØSS; A. ROSHOLM; A. LAURÉN 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

A phase 1, randomized, double-blind, pla

A phase 1, randomized, double-blind, placebo-controlled dose-escalating, safety, tolerability, pharmacokinetic, and pharmacodynamic study of oral recombinant human interleukin eleven (O-rhIl-11) in normal healthy subjects

✍ Cotreau, Monette M.; Stonis, Lucille; Schwertschlag, Ullrich S. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Pharmacokinetics and safety of single do

Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial

✍ Flanigan, Kevin M.; Voit, Thomas; Rosales, Xiomara Q.; Servais, Laurent; Kraus, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Pharmacokinetics and safety of single do

Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial

✍ Flanigan, Kevin M.; Voit, Thomas; Rosales, Xiomara Q.; Servais, Laurent; Kraus, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Duchenne muscular dystrophy (DMD) is a progressive, lethal neuromuscular disorder caused by the absence of dystrophin protein due to mutations of the dystrophin gene. Drisapersen is a 2′-__O__-methyl-phosphorothioate oligonucleotide designed to skip exon 51 in dystrophin pre-mRNA to restore the read

Efficacy of intralesional recombinant hu

Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial

✍ Gomez-Villa, Ramiro; Aguilar-Rebolledo, Francisco; Lozano-Platonoff, Adriana; Te 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Efficacy and safety of recombinant human

Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial

✍ H. SAITO; I. MARUYAMA; S. SHIMAZAKI; Y. YAMAMOTO; N. AIKAWA; R. OHNO; A. HIRAYAM 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB